Intrexon Corp. (XON) Trading Down 2%
Intrexon Corp. (NYSE:XON)’s share price fell 2% during trading on Tuesday . The company traded as low as $29.20 and last traded at $29.25, with a volume of 756,307 shares. The stock had previously closed at $29.84.
A number of brokerages have recently commented on XON. JMP Securities reiterated a “buy” rating on shares of Intrexon Corp. in a report on Sunday, July 17th. Zacks Investment Research upgraded shares of Intrexon Corp. from a “hold” rating to a “strong-buy” rating and set a $32.00 target price on the stock in a report on Tuesday, May 3rd. Vetr lowered shares of Intrexon Corp. from a “sell” rating to a “strong sell” rating and set a $22.26 target price on the stock. in a report on Wednesday, July 27th. Griffin Securities restated a “buy” rating and issued a $65.00 target price on shares of Intrexon Corp. in a report on Wednesday, May 18th. Finally, Wunderlich restated a “buy” rating and issued a $50.00 target price on shares of Intrexon Corp. in a report on Thursday, July 7th. Three investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. Intrexon Corp. currently has an average rating of “Buy” and an average price target of $41.71.
The stock’s market capitalization is $3.11 billion. The stock has a 50 day moving average price of $26.63 and a 200 day moving average price of $29.62.
Intrexon Corp. (NYSE:XON) last announced its quarterly earnings results on Tuesday, August 9th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.26) by $0.16. During the same quarter in the previous year, the business posted ($0.37) earnings per share. The business had revenue of $52.50 million for the quarter, compared to analyst estimates of $53.78 million. The firm’s revenue was up 17.0% on a year-over-year basis. On average, analysts predict that Intrexon Corp. will post ($1.36) earnings per share for the current fiscal year.
Several large investors recently bought and sold shares of the company. State of Wisconsin Investment Board boosted its stake in Intrexon Corp. by 2.5% in the fourth quarter. State of Wisconsin Investment Board now owns 35,410 shares of the company’s stock valued at $1,068,000 after buying an additional 880 shares in the last quarter. Bank of Montreal Can boosted its stake in Intrexon Corp. by 16.8% in the fourth quarter. Bank of Montreal Can now owns 40,010 shares of the company’s stock valued at $1,207,000 after buying an additional 5,742 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in Intrexon Corp. by 3.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 141,851 shares of the company’s stock valued at $4,278,000 after buying an additional 4,854 shares in the last quarter.
Intrexon Corporation (Intrexon) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company’s synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.